Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Apitoxin is a new biological drug for pain & inflammation and arthritis, approved by the Korean FDA on May 3, 2003 after 14 years of preclinical, animal, and phase I, II & III clinical studies More
Ob-X is composed of herbal extracts, and reduced body and adipose tissue weight and number and size of lipid vacuoles in the liver in animal studies; reduced body weight, waist circumference and visceral fat in human studies More
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
MRI contast medium More
Production process of C3 synthons by biotransformation. More
MRI contast medium More
Our client has developed a solution to successfully prevent unwanted earwax buildup. More
tissue for in vitro analysis of drug metabolic conversions More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jul 2010 - 85 pages - $750
Jul 2010 - 43 pages - $750
Nov 2010 - 22 pages - $750
Nov 2010 - 37 pages - $750
Nov 2010 - 63 pages - $750
Nov 2010 - 41 pages - $750
Nov 2010 - 24 pages - $750
Nov 2010 - 15 pages - $750
Nov 2010 - 16 pages - $750
Nov 2010 - 41 pages - $750
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Ayuverdic medicine
- Chinese medicine
- Dietetic
- Homeopathy
- Iron excess
- Kanpo medicine
- Other
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us